Market Research Logo

Companion Diagnostics Market by Technology (PCR, IHC, NGS, ISH), Indication (Breast cancer, NSCLC, Colorectal cancer, Neurological disorders, Infectious Diseases), End User (Pharmaceutical & Biopharmaceutical Companies, Reference Lab) - Global Forecast to

Companion Diagnostics Market by Technology (PCR, IHC, NGS, ISH), Indication (Breast cancer, NSCLC, Colorectal cancer, Neurological disorders, Infectious Diseases), End User (Pharmaceutical & Biopharmaceutical Companies, Reference Lab) - Global Forecast to 2022

“Global companion diagnostics market projected to grow at CAGR of 20.1%”
The global companion diagnostics market is projected to reach USD 6.51 billion by 2022 from USD 2.61 billion in 2017, at a CAGR of 20.1%. The growth of this market is majorly driven by the factors such as improvements in regulatory guidelines, growing need for targeted therapies, rising cancer incidence across the globe, and increasing collaborations and partnerships for companion diagnostics test development. However, uncertain reimbursement scenarios in different countries such as the U.S., the U.K., Japan, and Australia are expected to limit market growth.

“The assay kits & reagents segment is expected to grow at the fastest CAGR’
On the basis of product and service, the companion diagnostics market is segmented into assay kits & reagents, and software & services. The assay kits & reagents segment accounted for the largest share in 2016 and is expected to register the highest CAGR during the forecast period. The large share can be attributed to its wide range of applications in platforms such as PCR, NGS, IHC, and ISH.


“The oncology segment to dominate the global companion diagnostics market with largest share and fastest CAGR”
Based on indication, the companion diagnostics market is further categorized into oncology, infectious diseases, neurology, and other indications (including cardiovascular, inflammatory, and inherited diseases). In 2016, the oncology segment accounted for the largest share and is also the fastest growing segment of the market; this is primarily attributed to the growing incidence of cancer that enhanced the focus on cancer research and also broadened the role of companion diagnostics in this field.

‘”The pharmaceutical and biopharmaceutical companies segment is expected to grow at the fastest CAGR”
On the basis of end user, the pharmaceutical and biopharmaceutical companies segment accounted for the largest share of the market in 2016. This end-user segment is also expected to register the highest CAGR during the forecast period. The large share and growth of this market can be attributed to increasing and significant application of companion diagnostics in the drug development process.

“Asia-Pacific to witness the fastest growth during the forecast period (2017–2022)”
North America held the largest share of the global companion diagnostics market in 2016, while Asia-Pacific is expected to witness the highest growth during 2017 to 2022. Growing need for tailored therapeutics by the elderly population, increasing number of hospitals and diagnostic laboratories, and growing prevalence of life-threatening diseases are driving the growth of the companion diagnostics market in the Asia-Pacific region.

Break of primary participants was as mentioned below:
• By Company Type – Tier 1–45%, Tier 2–34%, and Tier 3–21%
• By Designation – C-level–14%, Director Level–10%, and Others–76%
• By Region – North America–40%, Europe–32%, Asia-Pacific–20%, and RoW–8%

Some of the major market players in the companion diagnostics market are F. Hoffmann-La Roche AG (Switzerland), Agilent Technologies, Inc. (U.S.), and QIAGEN N.V. (Netherlands) dominated the global companion diagnostics market. Some of the other players competing in this market are Thermo Fisher Scientific Inc. (U.S.), Abbott Laboratories, Inc. (U.S.), Myriad Genetics, Inc. (U.S.), Danaher Corporation (U.S.), Almac Group (U.S.), and Sysmex Corporation (Japan).

Research Coverage:
The report analyzes the companion diagnostics market and aims at estimating market size and future growth potential of this market based on various segments such as product and service, type of medical device, application, and region. The report also includes an in-depth regulatory analysis for various regions across the globe and competitive analysis of the key players in this market along with their company profiles, product and service offerings, recent developments, and key market strategies.

Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies.

This report provides insights on the following pointers:
• Market Penetration: Comprehensive information on product and service portfolios offered by the top players in the global companion diagnostics market. The report analyzes the global companion diagnostics market by product and service, technology, indication, end user, and region
• Product/Service Enhancement/Innovation: Detailed insights on upcoming trends and new product/service launches in the global companion diagnostics market
• Market Development: Comprehensive information on the lucrative emerging markets by product and service, type of medical device, application, and region
• Market Diversification: Exhaustive information about new product or product enhancements, growing geographies, recent developments, and investments in the global companion diagnostics market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, products, services, and capabilities of leading players in the global market.


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
      • MARKETS COVERED
      • YEARS CONSIDERED IN THE REPORT
    • CURRENCY
    • LIMITATIONS
    • STAKEHOLDERS
  • RESEARCH METHODOLOGY
    • MARKET SIZE ESTIMATION
    • DATA TRIANGULATION
      • KEY DATA FROM SECONDARY SOURCES
      • KEY DATA FROM PRIMARY SOURCES
      • ASSUMPTIONS FOR THE STUDY
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • GLOBAL COMPANION DIAGNOSTICS MARKET OVERVIEW
    • COMPANION DIAGNOSTICS MARKET, BY INDICATION
    • COMPANION DIAGNOSTICS MARKET, BY PRODUCT & SERVICES
    • COMPANION DIAGNOSTICS MARKET, BY TECHNOLOGY
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET DYNAMICS
      • DRIVERS
      • RESTRAINTS
        • Table COMPANION DIAGNOSTICS REIMBURSEMENT SCENARIO WORLDWIDE
      • OPPORTUNITIES
        • Table PARTNERSHIPS AND COLLABORATIONS FOR DEVELOPING NGS-BASED COMPANION DIAGNOSTIC TESTS
        • Table LIST OF CLINICAL TRIALS FOR COMPANION DIAGNOSTICS
      • CHALLENGE
  • COMPANION DIAGNOSTICS MARKET, BY PRODUCT & SERVICE
    • INTRODUCTION
      • Table GLOBAL COMPANION DIAGNOSTICS MARKET, BY PRODUCT AND SERVICE, 2015–2022 (USD MILLION)
    • ASSAY KITS AND REAGENTS
      • Table COMPANION DIAGNOSTICS MARKET FOR ASSAYS & REAGENTS, BY REGION, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: COMPANION DIAGNOSTICS MARKET FOR ASSAYS & REAGENTS, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table EUROPE: COMPANION DIAGNOSTICS MARKET FOR ASSAYS & REAGENTS, BY COUNTRY, 2015–2022 (USD MILLION)
    • SOFTWARE & SERVICES
      • Table COMPANION DIAGNOSTICS MARKET FOR SOFTWARE & SERVICES, BY REGION, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: COMPANION DIAGNOSTICS MARKET FOR SOFTWARE & SERVICES, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table EUROPE: COMPANION DIAGNOSTICS MARKET FOR SOFTWARE & SERVICES, BY COUNTRY, 2015–2022 (USD MILLION)
  • COMPANION DIAGNOSTICS MARKET, BY TECHNOLOGY
    • INTRODUCTION
      • Table GLOBAL COMPANION DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
    • POLYMERASE CHAIN REACTION
      • Table COMPARISON OF TISSUE SEQUENCING PLATFORMS FOR DETECTION OF RAS/BRAF MUTATION
      • Table COMPANION DIAGNOSTICS MARKET FOR PCR, BY REGION, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: COMPANION DIAGNOSTICS MARKET FOR PCR, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table EUROPE: COMPANION DIAGNOSTICS MARKET FOR PCR, BY COUNTRY, 2015–2022 (USD MILLION)
    • IMMUNOHISTOCHEMISTRY
      • Table COMPANION DIAGNOSTICS MARKET FOR IHC, BY REGION, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: COMPANION DIAGNOSTICS MARKET FOR IHC, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table EUROPE: COMPANION DIAGNOSTICS MARKET FOR IHC, BY COUNTRY, 2015–2022 (USD MILLION)
    • IN SITU HYBRIDIZATION
      • Table COMPANION DIAGNOSTICS MARKET FOR ISH, BY REGION, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: COMPANION DIAGNOSTICS MARKET FOR ISH, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table EUROPE: COMPANION DIAGNOSTICS MARKET FOR ISH, BY COUNTRY, 2015–2022 (USD MILLION)
    • NEXT-GENERATION SEQUENCING
      • Table COMPANION DIAGNOSTICS MARKET FOR NGS, BY REGION, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: COMPANION DIAGNOSTICS MARKET FOR NGS, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table EUROPE: COMPANION DIAGNOSTICS MARKET FOR NGS, BY COUNTRY, 2015–2022 (USD MILLION)
    • OTHER TECHNOLOGIES
      • Table COMPANION DIAGNOSTICS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: COMPANION DIAGNOSTICS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table EUROPE: COMPANION DIAGNOSTICS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2015–2022 (USD MILLION)
  • COMPANION DIAGNOSTICS MARKET, BY INDICATION
    • INTRODUCTION
      • Table GLOBAL COMPANION DIAGNOSTICS MARKET, BY INDICATION, 2015–2022 (USD MILLION)
    • ONCOLOGY
      • Table COMPANION DIAGNOSTICS MARKET FOR ONCOLOGY, BY TYPE, 2015–2022 (USD MILLION)
      • Table COMPANION DIAGNOSTICS MARKET FOR ONCOLOGY, BY REGION, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: COMPANION DIAGNOSTICS MARKET FOR ONCOLOGY, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table EUROPE: COMPANION DIAGNOSTICS MARKET FOR ONCOLOGY, BY COUNTRY, 2015–2022 (USD MILLION)
      • BREAST CANCER
      • LUNG CANCER
      • COLORECTAL CANCER
      • MELANOMA
      • GASTRIC CANCER
      • OTHER CANCERS
    • NEUROLOGY
      • Table COMPANION DIAGNOSTICS MARKET FOR NEUROLOGICAL DISORDERS, BY REGION, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: COMPANION DIAGNOSTICS MARKET FOR NEUROLOGICAL DISORDERS, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table EUROPE: COMPANION DIAGNOSTICS MARKET FOR NEUROLOGICAL DISORDERS, BY COUNTRY, 2015–2022 (USD MILLION)
    • INFECTIOUS DISEASES
      • Table COMPANION DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY REGION, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: COMPANION DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table EUROPE: COMPANION DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2015–2022 (USD MILLION)
    • OTHER INDICATIONS
      • Table COMPANION DIAGNOSTICS MARKET FOR OTHER INDICATIONS, BY REGION, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: COMPANION DIAGNOSTICS MARKET FOR OTHER INDICATIONS, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table EUROPE: COMPANION DIAGNOSTICS MARKET FOR OTHER INDICATIONS, BY COUNTRY, 2015–2022 (USD MILLION)
  • COMPANION DIAGNOSTICS MARKET, BY END USER
    • INTRODUCTION
      • Table GLOBAL COMPANION DIAGNOSTICS MARKET, BY END USER, 2015–2022 (USD MILLION)
    • PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
      • Table COMPANION DIAGNOSTICS MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY REGION, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: COMPANION DIAGNOSTICS MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table EUROPE: COMPANION DIAGNOSTICS MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2015–2022 (USD MILLION)
    • REFERENCE LABORATORIES
      • Table COMPANION DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES, BY REGION, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: COMPANION DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table EUROPE: COMPANION DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2015–2022 (USD MILLION)
    • OTHER END USERS
      • Table COMPANION DIAGNOSTICS MARKET FOR OTHER END USERS, BY REGION, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: COMPANION DIAGNOSTICS MARKET FOR OTHER END USERS, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table EUROPE: COMPANION DIAGNOSTICS MARKET FOR OTHER END USERS, BY COUNTRY, 2015–2022 (USD MILLION)
  • COMPANION DIAGNOSTICS MARKET, BY REGION
    • INTRODUCTION
      • Table COMPANION DIAGNOSTICS MARKET, BY REGION, 2015–2022 (USD MILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: COMPANION DIAGNOSTICS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: COMPANION DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: COMPANION DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: COMPANION DIAGNOSTICS MARKET, BY INDICATION, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: COMPANION DIAGNOSTICS MARKET FOR ONCOLOGY, BY TYPE, 2015–2022 (USD MILLION)
      • Table NORTH AMERICA: COMPANION DIAGNOSTICS MARKET, BY END USER, 2015–2022 (USD MILLION)
      • U.S.
        • Table U.S.: COMPANION DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015–2022 (USD MILLION)
        • Table U.S.: COMPANION DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
        • Table U.S.: COMPANION DIAGNOSTICS MARKET, BY INDICATION, 2015–2022 (USD MILLION)
        • Table U.S.: COMPANION DIAGNOSTICS MARKET FOR ONCOLOGY, BY TYPE, 2015–2022 (USD MILLION)
        • Table U.S.: COMPANION DIAGNOSTICS MARKET, BY END USER, 2015–2022 (USD MILLION)
      • CANADA
        • Table CANADA: COMPANION DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015–2022 (USD MILLION)
        • Table CANADA: COMPANION DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
        • Table CANADA: COMPANION DIAGNOSTICS MARKET, BY INDICATION, 2015–2022 (USD MILLION)
        • Table CANADA: COMPANION DIAGNOSTICS MARKET SIZE FOR ONCOLOGY, BY TYPE, 2015–2022 (USD MILLION)
        • Table CANADA: COMPANION DIAGNOSTICS MARKET, BY END USER, 2015–2022 (USD MILLION)
    • EUROPE
      • Table EUROPE: COMPANION DIAGNOSTICS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
      • Table EUROPE: COMPANION DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015–2022 (USD MILLION)
      • Table EUROPE: COMPANION DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
      • Table EUROPE: COMPANION DIAGNOSTICS MARKET, BY INDICATION, 2015–2022 (USD MILLION)
      • Table EUROPE: COMPANION DIAGNOSTICS MARKET FOR ONCOLOGY, BY TYPE, 2015–2022 (USD MILLION)
      • Table EUROPE: COMPANION DIAGNOSTICS MARKET, BY END USER, 2015–2022 (USD MILLION)
      • GERMANY
        • Table GERMANY: COMPANION DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015–2022 (USD MILLION)
        • Table GERMANY: COMPANION DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
        • Table GERMANY: COMPANION DIAGNOSTICS MARKET, BY INDICATION, 2015–2022 (USD MILLION)
        • Table GERMANY: COMPANION DIAGNOSTICS MARKET FOR ONCOLOGY, BY TYPE, 2015–2022 (USD MILLION)
        • Table GERMANY: COMPANION DIAGNOSTICS MARKET, BY END USER, 2015–2022 (USD MILLION)
      • FRANCE
        • Table FRANCE: COMPANION DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015–2022 (USD MILLION)
        • Table FRANCE: COMPANION DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
        • Table FRANCE: COMPANION DIAGNOSTICS MARKET, BY INDICATION, 2015–2022 (USD MILLION)
        • Table FRANCE: COMPANION DIAGNOSTICS MARKET FOR ONCOLOGY, BY TYPE, 2015–2022 (USD MILLION)
        • Table FRANCE: COMPANION DIAGNOSTICS MARKET, BY END USER, 2015–2022 (USD MILLION)
      • U.K.
        • Table U.K.: COMPANION DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015–2022 (USD MILLION)
        • Table U.K.: COMPANION DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
        • Table U.K.: COMPANION DIAGNOSTICS MARKET, BY INDICATION, 2015–2022 (USD MILLION)
        • Table U.K.: COMPANION DIAGNOSTICS MARKET FOR ONCOLOGY, BY TYPE, 2015–2022 (USD MILLION)
        • Table U.K.: COMPANION DIAGNOSTICS MARKET, BY END USER, 2015–2022 (USD MILLION)
      • REST OF EUROPE
        • Table ROE: COMPANION DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015–2022 (USD MILLION)
        • Table ROE: COMPANION DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
        • Table ROE: COMPANION DIAGNOSTICS MARKET, BY INDICATION, 2015–2022 (USD MILLION)
        • Table ROE: COMPANION DIAGNOSTICS MARKET FOR ONCOLOGY, BY TYPE, 2015–2022 (USD MILLION)
        • Table ROE: COMPANION DIAGNOSTICS MARKET, BY END USER, 2015–2022 (USD MILLION)
    • ASIA-PACIFIC
      • Table APAC: COMPANION DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015–2022 (USD MILLION)
      • Table APAC: COMPANION DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
      • Table APAC: COMPANION DIAGNOSTICS MARKET, BY INDICATION, 2015–2022 (USD MILLION)
      • Table APAC: COMPANION DIAGNOSTICS MARKET FOR ONCOLOGY, BY TYPE, 2015–2022 (USD MILLION)
      • Table APAC: COMPANION DIAGNOSTICS MARKET, BY END USER, 2015–2022 (USD MILLION)
    • REST OF THE WORLD
      • Table ROW: COMPANION DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2015–2022 (USD MILLION)
      • Table ROW: COMPANION DIAGNOSTICS MARKET, BY TECHNOLOGY, 2015–2022 (USD MILLION)
      • Table ROW: COMPANION DIAGNOSTICS MARKET, BY INDICATION, 2015–2022 (USD MILLION)
      • Table ROW: COMPANION DIAGNOSTICS MARKET FOR ONCOLOGY, BY TYPE, 2015–2022 (USD MILLION)
      • Table ROW: COMPANION DIAGNOSTICS MARKET, BY END USER, 2015–2022 (USD MILLION)
  • COMPETITIVE LANDSCAPE
    • INTRODUCTION
    • MARKET RANKING ANALYSIS
      • Table RANK OF COMPANIES IN THE COMPANION DIAGNOSTICS MARKET, 2016
    • COMPETITIVE LEADERSHIP MAPPING
      • VISIONARY LEADERS
      • INNOVATORS
      • DYNAMIC DIFFERENTIATORS
      • EMERGING COMPANIES
    • COMPETITIVE BENCHMARKING
      • STRENGTH OF PRODUCT PORTFOLIO (FOR 25 PLAYERS)
      • BUSINESS STRATEGY EXCELLENCE (FOR 25 PLAYERS)
  • COMPANY PROFILES
    • F. HOFFMANN-LA ROCHE AG
      • BUSINESS OVERVIEW
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS
    • AGILENT TECHNOLOGIES, INC.
      • BUSINESS OVERVIEW
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS
    • QIAGEN N.V.
      • BUSINESS OVERVIEW
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS
    • THERMO FISHER SCIENTIFIC INC.
      • BUSINESS OVERVIEW
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS
    • ABBOTT LABORATORIES, INC.
      • BUSINESS OVERVIEW
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS
    • BIOMÉRIEUX SA
      • BUSINESS OVERVIEW
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS
    • DANAHER CORPORATION
      • BUSINESS OVERVIEW
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS
    • ILLUMINA, INC.
      • BUSINESS OVERVIEW
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS
    • MYRIAD GENETICS, INC.
      • BUSINESS OVERVIEW
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS
    • ARUP LABORATORIES INC.
      • BUSINESS OVERVIEW
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS
    • SYSMEX CORPORATION
      • BUSINESS OVERVIEW
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS
    • HOLOGIC INC.
      • BUSINESS OVERVIEW
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS
    • NOVARTIS AG
      • BUSINESS OVERVIEW
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
    • ALMAC GROUP
      • BUSINESS OVERVIEW
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS
    • ABNOVA CORPORATION
      • BUSINESS OVERVIEW
      • STRENGTH OF PRODUCT PORTFOLIO
      • BUSINESS STRATEGY EXCELLENCE
      • RECENT DEVELOPMENTS
  • APPENDIX
    • INSIGHTS OF INDUSTRY EXPERTS
    • DISCUSSION GUIDE
    • KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report